Cargando…

The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs

Despite the fact that SARS-CoV-2 vaccines have been available in most parts of the world, the epidemic status remains grim with new variants emerging and escaping the immune protection of existing vaccines. Therefore, the development of more effective antigens and evaluation of their cross-protectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Wenqiang, He, Lihong, Lou, Huicong, Fan, Wenhui, Yang, Limin, Cheng, Gong, Liu, Wenjun, Sun, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226324/ https://www.ncbi.nlm.nih.gov/pubmed/35757743 http://dx.doi.org/10.3389/fimmu.2022.898520

Ejemplares similares

Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor
por: Andrade, Sonia Aparecida, et al.
Publicado: (2022)

Prediction of antibody binding to SARS-CoV-2 RBDs
por: Wang, Eric
Publicado: (2023)

Impact of mutations on the plant-based production of recombinant SARS-CoV-2 RBDs
por: Ruocco, Valentina, et al.
Publicado: (2023)

The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
por: Sun, Wenqiang, et al.
Publicado: (2021)

Low-Entropy Hydration Shells at the Spike RBD’s Binding Site May Reveal the Contagiousness of SARS-CoV-2 Variants
por: Yang, Lin, et al.
Publicado: (2023)

How Do Point Mutations Enhancing the Basic Character of the RBDs of SARS-CoV-2 Variants Affect Their Transmissibility and Infectivity Capacities?
por: Barre, Annick, et al.
Publicado: (2022)

Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2
por: Zhang, Zhi-Bi, et al.
Publicado: (2022)

Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses
por: Xu, Zepeng, et al.
Publicado: (2022)

Structural Basis of Rnd1 Binding to Plexin Rho GTPase Binding Domains (RBDs)
por: Wang, Hui, et al.
Publicado: (2011)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Lou, Fuxing, et al.
Publicado: (2021)

Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs
por: Tan, Enqing, et al.
Publicado: (2021)

A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice
por: He, Lihong, et al.
Publicado: (2022)

A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates
por: Yang, Limin, et al.
Publicado: (2021)

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques
por: He, Qian, et al.
Publicado: (2022)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates
por: Wu, Yixin, et al.
Publicado: (2022)

Molecular Pathology of Rare Bleeding Disorders (RBDs) in India: A Systematic Review
por: Kulkarni, Bipin P., et al.
Publicado: (2014)

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
por: Tian, Dandan, et al.
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021)

Nasal delivery of thermostable and broadly neutralizing antibodies protects mice against SARS-CoV-2 infection
por: Fan, Wenhui, et al.
Publicado: (2022)

Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants
por: Antonio, Eduardo Cheuiche, et al.
Publicado: (2022)

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
por: Ma, Qinhai, et al.
Publicado: (2023)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
por: Zhang, Yandi, et al.
Publicado: (2021)

The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants
por: Thompson, Robin N., et al.
Publicado: (2023)

Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2
por: Braun, Molly R., et al.
Publicado: (2023)

Computational modelling of potentially emerging SARS-CoV-2 spike protein RBDs mutations with higher binding affinity towards ACE2: A structural modelling study
por: Khan, Abbas, et al.
Publicado: (2022)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response
por: Chen, Li, et al.
Publicado: (2022)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
por: Martín-Galiano, Antonio J., et al.
Publicado: (2021)

CD8(+) T-cell immune escape by SARS-CoV-2 variants of concern
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
por: Escudero-Pérez, Beatriz, et al.
Publicado: (2023)

Improving care pathways for people living with rare bone diseases (RBDs): outcomes from the first RBD Summit
por: Chandran, Manju, et al.
Publicado: (2023)

Omicron variants of SARS-CoV-2 and long COVID
por: Yang, Chengliang, et al.
Publicado: (2022)

Defining the pediatric response to SARS-CoV-2 variants
por: Ho, Reanne M., et al.
Publicado: (2023)

Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
por: Mooij, Petra, et al.
Publicado: (2022)

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals
por: Szekanecz, Zoltán, et al.
Publicado: (2023)

Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2
por: Barbier, Mariette, et al.
Publicado: (2022)

Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
por: Ahluwalia, Pankaj, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pq3kifr22bm1f9teq6i6a156jm